Maintenance medication for asthma includes which option that reduces mucus, secretion, and airway edema?

Maintenance medication for asthma includes which option that reduces mucus, secretion, and airway edema?

• A. Inhaled corticosteroids
• B. Albuterol
• C. Ipratropium
• D. Antihistamines

Answer: (A)

Controlling airway inflammation is the foundation of long-term asthma management. Inhaled corticosteroids are the maintenance therapy that targets this inflammation directly, leading to reduced edema of the airway mucosa and less mucus production over time. By calming the inflammatory process, they decrease airway hyperresponsiveness and prevent symptoms and exacerbations, which is why they are the best choice for ongoing, daily control. Rescue bronchodilators like albuterol relieve acute bronchospasm quickly but don’t address the underlying inflammation or reduce edema and mucus chronically. Anticholinergics such as ipratropium can aid bronchodilation and may reduce secretions, but they aren’t the primary maintenance therapy for reducing airway inflammation. Antihistamines don’t address the inflammatory processes in the lower airways that drive chronic asthma control. Therefore, the inhaled corticosteroids best meet the goal of maintenance therapy to reduce mucus, secretion, and airway edema.

Controlling airway inflammation is the foundation of long-term asthma management. Inhaled corticosteroids are the maintenance therapy that targets this inflammation directly, leading to reduced edema of the airway mucosa and less mucus production over time. By calming the inflammatory process, they decrease airway hyperresponsiveness and prevent symptoms and exacerbations, which is why they are the best choice for ongoing, daily control.

Rescue bronchodilators like albuterol relieve acute bronchospasm quickly but don’t address the underlying inflammation or reduce edema and mucus chronically. Anticholinergics such as ipratropium can aid bronchodilation and may reduce secretions, but they aren’t the primary maintenance therapy for reducing airway inflammation. Antihistamines don’t address the inflammatory processes in the lower airways that drive chronic asthma control. Therefore, the inhaled corticosteroids best meet the goal of maintenance therapy to reduce mucus, secretion, and airway edema.